Transient Expression of Reck Under Hepatic Ischemia/Reperfusion Conditions Is Associated with Mapk Signaling Pathways.


Journal

Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414

Informations de publication

Date de publication:
11 05 2020
Historique:
received: 08 01 2020
revised: 04 05 2020
accepted: 07 05 2020
entrez: 15 5 2020
pubmed: 15 5 2020
medline: 7 4 2021
Statut: epublish

Résumé

In this study, we demonstrated the involvement of matrix metalloproteinases (MMPs) in hepatic ischemia/reperfusion (I/R) injury. Our aim is to evaluate the impact of reperfusion on I/R-related changes in RECK, an MMP modulator, and mitogen-activated protein kinase (MAPKs) pathways (ERK, p38, and JNK). Male Wistar rats were either subjected to 60 min partial-hepatic ischemia or sham-operated. After a 60 min or 120 min reperfusion, liver samples were collected for analysis of MMP-2 and MMP-9 by zymography and RECK, TIMP-1, and TIMP-2 content, MAPKs activation (ERK1/2, JNK1/2, and p38), as well as iNOS and eNOS by Western blot. Serum enzymes AST, ALT, and alkaline-phosphatase were quantified. A transitory decrease in hepatic RECK and TIMPs was associated with a transitory increase in both MMP-2 and MMP-9 activity and a robust activation of ERK1/2, JNK1/2, and p38 were detected at 60 min reperfusion. Hepatic expression of iNOS was maximally upregulated at 120 min reperfusion. An increase in eNOS was detected at 120 min reperfusion. I/R evoked significant hepatic injury in a time-dependent manner. These findings provide new insights into the underlying molecular mechanisms of reperfusion in inducing hepatic injury: a transitory decrease in RECK and TIMPs and increases in both MAPK and MMP activity suggest their role as triggering factors of the organ dysfunction.

Identifiants

pubmed: 32403397
pii: biom10050747
doi: 10.3390/biom10050747
pmc: PMC7277810
pii:
doi:

Substances chimiques

GPI-Linked Proteins 0
Reck protein, rat 0
Tissue Inhibitor of Metalloproteinases 0
Tumor Suppressor Proteins 0
Nitric Oxide Synthase Type II EC 1.14.13.39
Nitric Oxide Synthase Type III EC 1.14.13.39
Matrix Metalloproteinases EC 3.4.24.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Curr Opin Organ Transplant. 2011 Feb;16(1):34-40
pubmed: 21150609
Drug Des Devel Ther. 2018 Nov 29;12:4067-4082
pubmed: 30568428
Exp Mol Med. 2006 Aug 31;38(4):408-16
pubmed: 16953120
Am J Pathol. 2009 Jun;174(6):2265-77
pubmed: 19443702
Biomed Res Int. 2014;2014:327537
pubmed: 25013773
J Invest Surg. 2008 Jul-Aug;21(4):215-26
pubmed: 18615319
Chem Biol Interact. 2013 May 25;203(3):580-7
pubmed: 23566884
FASEB J. 2002 Jan;16(1):93-5
pubmed: 11709491
Hepatology. 2008 Jan;47(1):186-98
pubmed: 17880014
Brain Behav. 2018 Aug;8(8):e01079
pubmed: 30035384
Int J Mol Sci. 2019 Apr 10;20(7):
pubmed: 30974915
J Surg Res. 2003 Feb;109(2):101-9
pubmed: 12643850
Mol Biol Cell. 2018 Aug 1;29(15):1825-1838
pubmed: 29874120
J Cell Mol Med. 2008 Dec;12(6B):2781-9
pubmed: 18194466
Biochim Biophys Acta. 2014 Mar;1843(3):603-17
pubmed: 24333402
Cell. 2001 Dec 14;107(6):789-800
pubmed: 11747814
Transplantation. 1999 Sep 27;68(6):803-13
pubmed: 10515381
Arch Pharm Res. 2011 Jan;34(1):137-45
pubmed: 21468925
Am J Physiol. 1999 May;276(5):G1069-73
pubmed: 10329995
Surgery. 2002 Mar;131(3):344-9
pubmed: 11894041
Int Immunopharmacol. 2019 May;70:435-445
pubmed: 30856394
Oxid Med Cell Longev. 2016;2016:5271251
pubmed: 28053692
Sci Rep. 2017 Nov 9;7(1):15175
pubmed: 29123239
Toxicol Pathol. 2012 Jul;40(5):722-30
pubmed: 22549974
Matrix Biol. 2015 May-Jul;44-46:147-56
pubmed: 25599939
Eur J Histochem. 2017 May 30;61(2):2798
pubmed: 28735525
J Leukoc Biol. 2006 Jun;79(6):1295-305
pubmed: 16551680
J Clin Lab Anal. 2016 Jan;30(1):36-40
pubmed: 25278269
Biochim Biophys Acta. 2010 May;1803(5):608-16
pubmed: 20080132
Hepatology. 2012 Sep;56(3):1074-85
pubmed: 22407827
Br J Surg. 2006 Jun;93(6):752-61
pubmed: 16671069
Histol Histopathol. 2008 Aug;23(8):1003-10
pubmed: 18498076
Curr Pharm Des. 2006;12(23):2923-34
pubmed: 16918422
J Invest Surg. 2008 May-Jun;21(3):119-26
pubmed: 18569431

Auteurs

Andrea Ferrigno (A)

Department of Internal Medicine and Therapeutics, University of Pavia, 27100 Pavia, Italy.

Laura G Di Pasqua (LG)

Department of Internal Medicine and Therapeutics, University of Pavia, 27100 Pavia, Italy.

Giuseppina Palladini (G)

Department of Internal Medicine and Therapeutics, University of Pavia, 27100 Pavia, Italy.
Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.

Clarissa Berardo (C)

Department of Internal Medicine and Therapeutics, University of Pavia, 27100 Pavia, Italy.

Roberta Verta (R)

Department of Drug Science and Technology, University of Turin, 10125 Turin, Italy.

Plinio Richelmi (P)

Department of Internal Medicine and Therapeutics, University of Pavia, 27100 Pavia, Italy.

Stefano Perlini (S)

Department of Internal Medicine and Therapeutics, University of Pavia, 27100 Pavia, Italy.
Emergency Department, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.

Debora Collotta (D)

Department of Drug Science and Technology, University of Turin, 10125 Turin, Italy.

Massimo Collino (M)

Department of Drug Science and Technology, University of Turin, 10125 Turin, Italy.

Mariapia Vairetti (M)

Department of Internal Medicine and Therapeutics, University of Pavia, 27100 Pavia, Italy.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH